APA (7th ed.) Citation

Shinkle, M. (2026). Orziloben Snags FDA Orphan Drug Status for Intestinal Failure-Associated Liver Disease. Healio Gastroenterology, 12(4), 12.

Chicago Style (17th ed.) Citation

Shinkle, Matthew. "Orziloben Snags FDA Orphan Drug Status for Intestinal Failure-Associated Liver Disease." Healio Gastroenterology 12, no. 4 (2026): 12.

MLA (9th ed.) Citation

Shinkle, Matthew. "Orziloben Snags FDA Orphan Drug Status for Intestinal Failure-Associated Liver Disease." Healio Gastroenterology, vol. 12, no. 4, 2026, p. 12.